Articles

Find an Article

Filter articles

Showing 3181 to 3190 of 3395 results

Consumers first: GlaxoSmithKline on trademarks

01-12-2010

People often think that IP in the healthcare sector is all about patents. But while GlaxoSmithKline certainly has a patent portfolio to protect, it also takes a strident approach to enforcing its trademarks and defending its brands.

Back to basics: renewing the foundations of innovation

01-12-2010BiotechnologyJim Greenwood

The economic crisis has caused companies and governments alike to reassess their spending. Jim Greenwood explains why imperilling IP protection for the biotechnology industry would be the worst possible outcome.

ANDA one, ANDA too?

01-12-2010David K.S. Cornwell and Kevin W. McCabe

David Cornwell and Kevin McCabe describe the complex process for obtaining FDA approval for generic and biosimilar drugs, and managing patent disputes with approved companies.

Will the future of gene patents be "markedly different" after Myriad?

01-12-2010BiotechnologyLee Crews and Vicki Norton

A US district court decision threatens the future of so-called ‘gene patents’ in the US. Lee Crews and Vicki Norton look at the current position and assess the possible futures for the case.

Counterfeit medicines - the quintessential borderless crime

01-12-2010

The global spread of counterfeit pharmaceuticals presents a formidable challenge to public health. WIPR asked lawyers from Baker & McKenzie offices around the world about this growing menace and what IP rights owners can do.

Towards an EU patent

EPO, EU01-12-2010

People have been talking about a single Europe-wide patent for more than 60 years, although political concerns always seem to get in the way. WIPR talks to four key stakeholders about what the future holds.

France catches up

France01-12-2010

The European Patent Convention 2000 introduced new provisions enabling a patentee to limit the claims of its patent, even though the patent has been definitively granted. Now similar provisions have been introduced into French law.

Taking the next step in brand and patent security

01-12-2010Dean Hart

While pharmaceutical companies suffer greatly from the counterfeit drugs trade, it is important to remember that, ultimately, it is patients who suffer the most. Dean Hart explains.

Prepare for a clash of IP cultures

01-12-2010Gary Johnson

Consumer-grade medical devices are growing in popularity across the developed world in response to lifestyle-related health problems and an increased demand for personal influence over medical decisions.

Harnessing IP: strategies for SMEs

India01-12-2010Kajigailiu Gaiduwan Kamei

With the continuous shift towards a knowledge-based and innovation-driven economy, IP is a key consideration in day-to-day business decisions. But SMEs are not always as well versed as they should be, says Kajigailiu Gaiduwan Kamei.

Showing 3181 to 3190 of 3395 results

WIPR